Author:
Kim J.H.,Oh J.Y.,Park B.H.,Lee D.E.,Kim J.S.,Park H.E.,Roh M.S.,Je J.E.,Yoon J.H.,Thorne S.H.,Kirn D.,Hwang T.H.
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference49 articles.
1. Replication-selective virotherapy for cancer: biological principles, risk management and future directions;Kirn;Nat. Med.,2001
2. Replicating vectors for gene therapy of cancer: risks, limitations and prospects;Russell;Eur. J. Cancer,1994
3. Recent progress in the battle between oncolytic viruses and tumours;Parato;Nat. Rev., Cancer,2005
4. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus;Stojdl;Nat. Med.,2000
5. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents;Heise;Nat. Med.,1997
Cited by
268 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献